| Dear Voornaam
Thank you to everyone who took part in our recent survey on the state of global collaboration post-Brexit. One message that came through very clearly was your continued support for the UK to rejoin Horizon Europe.
It has been widely reported that negotiations between UK and European officials are close to a deal, with the final say coming from Prime Minister Rishi Sunak and European Commission President Ursula von der Leyen.
We’ve leveraged your insights and support on this to once again make a strong call to both the UK and EU governments to close the deal and end two and a half years of uncertainty that has frustrated scientists and damaged the UK’s scientific reputation. |
|
|---|
|
|---|
|
|
Funding & Research Opportunities |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
THE APPRAISAL PODCAST WITH IAIN FOULKES - EPISODE 2 OUT NOW What is the role of Cancer Research UK and our innovation arm, Cancer Research Horizons, in the biotech and pharma space?
In this new episode, Executive Director of Research & Innovation at Cancer Research UK and CEO of Cancer Research Horizons, Iain Foulkes discusses Cancer Research Horizons’ unique position within that space, and how it helps us bridge the gap between research and the market.
Anchored by our Scientific Features Editor, Phil Prime, The Appraisal brings you crisp insight and analysis from the sharp end of research leadership. |
|
|---|
|
|---|
|
|
LUNG CANCER IN NEVER SMOKERS Did you know the cause of lung cancer in people who don't smoke?
Fábio Gomes, Consultant Medical Oncologist at The Christie NHS Foundation Trust, talks about how you only need lungs to get lung cancer in the new episode of One in Two: Manchester Cancer Research Podcast.
Tune into the podcast to find out more about Fábio’s research on the anaplastic lymphoma kinase positive (ALK+) mutation in Non-Small Cell Lung Cancer. |
|
|---|
| EXPLORE THE AGENDA FOR CANCER RESEARCH HORIZONS INNOVATION SUMMIT Cancer Research Horizons' Innovation Summit is back on 21 November.
Join us for a day of networking and inspiring talks from researchers who have successfully translated their research into commercial products.
Speakers include Simon Boulton (The Francis Crick Institute), Phil Clare (Queen Mary Innovation), Jason Mellad (Start Codon) and Barbara Domayne-Hayman (KQ Labs & The Francis Crick Institute). |
|
|---|
|
|---|
|
|
CHECK OUT OUR LATEST GRANT AWARDEES We're excited to unveil the latest grant awardees selected by our Prevention and Population Research Committee back in May:
Our Project Awardees include James Yarmolinsky, Richard Martin, Jenny Donovan, Freddy Hamdy, David Neal and Doug Easton, while Walid Khaled, Sara Pensa and Kwee Yong received Biology to Prevention Awards to develop new and targeted preventive interventions. |
|
|---|
|
|---|
|
|
REGISTER FOR DATA-DRIVEN CANCER RESEARCH CONFERENCE Interested in data-enabled cancer research? Catch us at our new data-driven cancer research conference next spring.
Eric Aboagye (Imperial College London) and Saiam Ahmed (University College London) have now joined our programme committee alongside Niels Peek (University of Manchester), Eva Morris (University of Oxford), Philip Dunne (Queens University Belfast) and Debbie Keatley. Their interdisciplinary perspectives and data expertise will help us create an event that will build a data community of excellence, enable new collaborations, and unleash the potential of cancer data to drive discovery and innovation.
Join us in Manchester on 27—28 February 2024 to hear about exciting data science and explore topics such as patient and public involvement in research design, health data access and the latest in AI approaches for cancer research. |
|
|---|
|
|---|
|
|
REGISTER FOR THE MOLECULAR ANALYSIS FOR PRECISION ONCOLOGY CONGRESS 2023 Are you working in precision oncology and translational research?
It's your last chance to save on registration for the MAP Congress 2023 on 4-6 October in Paris. Across three days, you'll hear about the latest data and discoveries in precision medicine, cancer-stromal interactions, clonal evolution and metastatic dissemination, and join a new 'RoadMAP to the clinic' day delving into the next wave of pan-cancer clinical trials.
Register before 13 September. |
|
|---|
| JOIN THE LEAN LAUNCH PROGRAMME TO DEVELOP YOUR ENTREPRENEURIAL SKILLS If you want to pitch your oncology-related research ideas to experienced panel of funders, stakeholders and investors, we have the right opportunity for you.
Join the Lean Launch Programme, the leading online pre-accelerator to realise your passion for making cancer research stronger. Take part and engage with technical and industry experts, receive funding to carry out market testing and expand your existing skillset into marketing and business.
Create real world impact with this 10-week market discovery programme run in partnership with our innovation arm, Cancer Research Horizons and Queen’s University Belfast and its NxNw Consortium. |
|
|---|
|
|---|
|
|
| | | Online 4:00 PM 27 September 2023 |
|
|---|
|
|---|
| | | Paris, France 04 October 2023 |
|
|---|
|
|---|
| | | London, UK 10 October 2023 |
|
|---|
|
|---|
| | | Liverpool, UK 18 October 2023 |
|
|---|
|
|---|
| | | Cambridge, UK 03 November 2023 |
|
|---|
|
|---|
| | | London, UK 14 November 2023 |
|
|---|
|
|---|
| | | Manchester. UK 17 November 2023 |
|
|---|
|
|---|
| | | London, UK 21 November 2023 |
|
|---|
|
|---|
| | | Manchester, UK 27 February 2024 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
